CMS’ decision to exclude digital health from its proposal for the Medicare Diabetes Prevention Program (DPP) has caused a controversy, explained Paul Chew, MD, chief medical officer of Omada Health.
CMS’ decision to exclude digital health from its proposal for the Medicare Diabetes Prevention Program (DPP) has caused a controversy, explained Paul Chew, MD, chief medical officer of Omada Health.
Transcript
As you know, CMS has proposed to delay full participation of digital health providers in the Medicare DPP when it launches in April 2018. Is CMS’ call for more evidence legitimate, or this barrier emblematic of others that digital health has encountered?
One of the greatest innovations in the digital approach or the diabetes prevention approach has been the CMS program that will go into effect next April. As you may know at this stage they are approving and reimbursing DPP programs that have been approved or certified by CDC. They are still getting comments for digital diabetes prevention. We feel very strongly that the evidence base for seniors is strong for diabetes prevention already. We’ve published 2 articles on the effectiveness of the Omada program with results that are even better than the YMCA program, which is the basis for the CMS program. The second study showed that the return on investment is even sooner than the 1- to 2-year time period for seniors. So overall, we felt the evidence base is there.
Most importantly, if the CMS benefit is to its full realization for seniors, we have to access seniors who may not have the ability or the desire to go to a face-to-face program once a week. We have to be able to provide access digitally for those participants, and we also have to recognize that there’s only a very thin slice of time you spend in a face-to-face program, whereas in a digital program, it’s constantly accessible—when you need it and where you need it.
Where do you see the digital health and the DPP heading in the next 5 years?
The next 5 years is going to be very important as we go forward in digital health, because we will get a critical mass of experience. It will become even more clear that diabetes prevention is needed. The CMS program, the MACRA, and the MIPS initiatives to encourage screening—I believe—will make it easier for physicians and other healthcare providers to recognize and refer prediabetes patients.
Dr Kathy Zackowski Discusses the Importance of Rehabilitation Research and Trials in MS
April 26th 2024Kathy Zackowski, PhD, National MS Society, expresses the inherent value of quality rehabilitation trials for broadening clinical understandings of multiple sclerosis (MS) and bettering patient outcomes.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Prices for care at hospital trauma centers vary across hospitals; drug shortages reached a record high during the first quarter of 2024; although 3 of the biggest makers of asthma inhalers pledged to cap out-of-pocket costs for some US patients at $35, these do not apply to daily inhalers used by the youngest kids with asthma.
Read More
Commonwealth Fund Report Details Pervasive Racial and Ethnic Disparities in US Health Care, Outcomes
April 18th 2024Using 25 health system performance indicators, the Commonwealth Fund 2024 State Health Disparities Report evaluated racial and ethnic disparities in health care and health outcomes both within and across US states and highlighted the urgent need for equitable health care policies and practices in the US.
Read More